Autoimmunity reviews · 2008
Recurrent pericarditis: infectious or autoimmune?
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Brucato Antonio, Maestroni Silvia, Cumetti Davide, Thiella Giuseppe, Alari Gabriella, Brambilla Giovanni, Imazio Massimo, Doria Andrea, Palmieri Giancarlo, Adler Yehuda
Аннотация
The etiology and pathogenesis of idiopathic recurrent acute pericarditis (IRAP) remain controversial standing like a bridge that crosses infectious, autoimmune and autoinflammatory pathways. Anything may cause acute pericarditis; Echo-virus, and Coxsackie are the most frequently involved viruses, Mycobacterium tuberculosis and Coxiella burnetii the most common bacteria, but in 85% of cases it remains "idiopathic". Recurrences occur in up to 20-50% of patients. An immuno-mediated pathogenesis is suggested by the presence of pro-inflammatory cytokines in pericardial fluid, the presence of antinuclear autoantibodies (ANA) in sera of the patients, the occurrence of new autoimmune diagnoses and the good response to anti-inflammatory or immunosuppressive therapy. Nonsteroidal anti-inflammatory drugs (NSAIDs) must be used at recommended dosages, till the resolution of symptoms and normalization of C-reactive protein and erythrocyte sedimentation rate. Corticosteroids should be used rarely, at low doses, with an extremely low tapering and with osteoporosis prevention. Colchicine leads to a clinically important and statistically significant benefit, reducing recurrences by 50%. The long term outcome of IRAP is good, without evidence of constriction even after a very long follow-up.
Предметные рубрики MeSH
Acute DiseaseAdrenal Cortex HormonesAnti-Inflammatory Agents, Non-SteroidalAntibodies, AntinuclearBacterial InfectionsC-Reactive ProteinColchicineCoxiella burnetiiDrug InteractionsEnterovirusEnterovirus InfectionsHumansMycobacterium tuberculosisOsteoporosisPericarditisPrognosisSecondary PreventionTreatment Outcome